🇺🇸 FDA
Patent

US 11801241

Muscarinic M2 receptor blockade to delay or prevent onset of progressive memory decline

granted A61KA61K31/4545A61K9/0053

Quick answer

US patent 11801241 (Muscarinic M2 receptor blockade to delay or prevent onset of progressive memory decline) held by United States Government as represented by the Department of Veterans Affairs expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/4545, A61K9/0053, A61P, A61P25/28